Illustrative image – not actual.Serum Institute of India will invest Rs 1,000 crore to set up a new manufacturing facility in Pune.
The vaccine manufacturing plant will be developed over the next three years.
The company will manufacture vaccines for pneumonia, rotavirus, dengue and many other diseases, in the plant.
Presently, Serum Institute has two manufacturing plants in Pune and the Netherlands.
Apart from expanding in Pune, it will also boost its manufacturing in the Netherlands. The investment for the acquisition and expansion of the Bilthoven Biologicals cumulatively over last two years is around 200 million euros.
More Project Info:
